InvestorsHub Logo
Followers 2543
Posts 250734
Boards Moderated 34
Alias Born 05/06/2014

Re: Giovanni post# 651

Thursday, 02/15/2018 12:54:55 PM

Thursday, February 15, 2018 12:54:55 PM

Post# of 2139
$CTRV Taking a broader look brokerage firms’ analysts on the street with an expectant view have Contravir Pharmaceut (NASDAQ:CTRV) high price target of $4 and with a conservative view have low price target of $4.

Maxim Group “Initiates Coverage on” Contravir Pharmaceut (NASDAQ:CTRV) in a research note issued to investors on 5/06/16 to Buy.

https://expertgazette.com/2018/02/13/analysts-alert-contravir-pharmaceut-ctrv/Analysts Alert: Contravir Pharmaceut (CTRV)
ExpertGazette - 2d ago


Contravir Pharmaceut (NASDAQ:CTRV) shares traded 16.4% up during most recent session to reach at the closing price of $0.29.Analysts Alert: Contravir Pharmaceut (CTRV)
ExpertGazette - 2d ago


Contravir Pharmaceut (NASDAQ:CTRV) shares traded 16.4% up during most recent session to reach at the closing price of $0.29.

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEPA News